ALL >> Health >> View Article
Influenza Diagnostics Market - Opportunities, Key Players, Market Size And Share
The global influenza diagnostics market is projected to reach USD 1.1 billion by 2026 from USD 0.8 billion in 2021, at a CAGR of 7.7%. Market growth is driven by rising demand for rapid disease diagnosis, increasing prevalence of influenza and growth in influenza research for diagnostic technologies.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222985562
Opportunity: Advancements in genomic and proteomic technologies
The Human Genome Project and advances in molecular and biomedical technologies have generated a vast amount of data, which have resulted in the development of a multitude of assays and technologies useful for the diagnosis and management of influenza infections. These new technologies, based on genomic techniques (such as PCR-based) and proteomics (such as microarray-based detection), help discover new influenza viruses. They also enable better surveillance and rapid diagnosis of infectious diseases which serves as an opportunity for the market.
Some key players in the influenza diagnostics market (2021- 2026)
Thermo Fisher Scientific, Inc. ...
... (US
Becton, Dickinson and Company (US)
F. Hoffmann-LA Roche AG (Switzerland)
Hologic, Inc. (US)
Abbott Laboratories, Inc. (Us)
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=222985562
North America is the largest regional market for influenza diagnostics market
The global influenza diagnostics market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global influenza diagnostics market. The North American influenza diagnostics market's growth can be attributed to the growth in influenza research for diagnostic technologies and increasing prevalence of influenza.
Recent Developments
In May 2021 Becton, Dickinson and Company (US) received FDA approval for the BD Veritor Plus System, which is used to detect SARS-CoV-2, influenza A, and influenza B.
In March 2021, Abbott Laboratories, Inc. (US) received emergency use authorization (EUA) from the FDA for a laboratory PCR assay that detects and differentiates SARS-COV-2, flu A, flu B, and RSV in one test.
In February 2021, Becton, Dickinson and Company (US) received approval from the FDA for the emergency use authorization (EUA) for a new molecular diagnostic test for both SARS-CoV-2 and influenza A+B.
Add Comment
Health Articles
1. The Secret Behind Thicker Hair: Best Anti Hair Fall Oil For MenAuthor: Nurture by Anita
2. Complete Guide To Choosing The Right Child Specialist
Author: Shreeja bhatt
3. Spine Surgery In India: Quick Recovery In Minimally Invasive Spine Surgery
Author: Andy
4. Spitting Pink In The Sink: Why Your Gums Randomly Bleed
Author: Gentle and Caring detistry
5. Why Regular Wisdom Teeth Evaluations Matter More Than Most People Realize
Author: Harry Singh
6. Choosing The Right Food Packaging Printing Partner For Your Business
Author: Walid Shaikh
7. Vet's Best Nature's Health Care Plaque & Tartar Dental Powder For Dogs
Author: VetSupply
8. Vital Energy & Wellness Blend For Daily Strength And Stamina Support
Author: Erweit Nutrition
9. Vet's Best Nature's Health Care Dental Silicone Finger Brushes For Dogs & Cats
Author: VetSupply
10. Vet's Best Nature's Health Care Dental Gel Toothpaste For Dogs
Author: VetSupply
11. Find Sirolimus 1 Mg Tablet Price In India | Supplier & Exporter
Author: Oddway International
12. Dental Clinic In South Bangalore: Areas Served, Locations & How To Reach Us
Author: Toothpriority
13. Vet's Best Nature's Health Care Dental Care Kits For Puppies
Author: VetSupply
14. Vet's Best Nature's Health Care Dental Care Kit For Dogs
Author: VetSupply
15. Vet's Best Nature's Health Care Clean Teeth Finger Pads For Dogs & Cats
Author: VetSupply






